Lab901

About:

Lab901 engages in the development and production of automated gel electrophories.

Top Investors: Archangels, Scottish Enterprise, Alliance Trust

Description:

Lab901 Limited engages in the development and production of automated gel electrophories in the United Kingdom. It offers ScreenTape P200 variant, which allows scientists in expressing and purifying recombinant proteins and monoclonal antibodies to carry out SDS-PAGE and analysis; ScreenTape R6K that is developed for reproducible RNA characterisation and quality control; and ScreenTape D800, which separates DNA fragments.